The headline numbers for DexCom (DXCM) give insight into how the company performed in the quarter ended December 2024, but it may be worthwhile to compare some of its key metrics to Wall Street ...

Evaluate the expected performance of DexCom (DXCM) for the quarter ended December 2024, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics ...

A U.K. court has ruled against Abbott in a trademark infringement case the company had brought over the design of a rival ...

Mark will continue to play a vital role as we move forward, now with a sharper focus on leading our technological vision and ensuring that innovation is at the forefront of our product development." ...

G6 continuous glucose monitor (CGM) receivers deliver glucose readings and alerts. However, certain devices may experience an ...

Leonardo DRS, Inc. announced today that it was awarded a contract to provide and integrate the latest Battle Management Systems (BMS) C4I hardware and software into new Royal Thailand Army combat ...

Senseonics announced today that it filed for CE mark for its Eversense 365 continuous glucose monitor (CGM) system.

Adults in the US who want to measure their blood glucose levels using a wearable sensor will soon be able to buy one over-the-counter (OTC) for the first time. The FDA has cleared Dexcom’s Stelo ...

Now that we're a month out from CES, these are the trends that have stuck with me. Yes, AI is on the list, of course, but so ...

(2024) Freestyle Libre 3 User Guide ART49385-001 Rev. A 04/24 3 Dexcom (2024) G7 User Guide AW00078-10 Rev ... Evaluation of the Accuracy of a Novel Implanted Continuous Glucose Sensor: PRECISE II.

DANIEL ADAJI explains ways smart gadgets enhance early detection of stroke and other non-communicable diseases, the technology behind them, and their potential to revolutionise healthcare ...

We have excluded third-party attorney’s fees, costs, and expenses incurred by Dexcom exclusively in connection with Dexcom’s patent infringement litigation against Abbott Diabetes Care, Inc., as ...